Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-27T06:23:31.715Z Has data issue: false hasContentIssue false

Alteration of postprandial glucose and insulin concentrations with meal frequency and composition

Published online by Cambridge University Press:  18 September 2014

Jill A. Kanaley*
Affiliation:
Department of Nutrition and Exercise Physiology, University of Missouri, 217 Gwynn Hall, Columbia, MO65211, USA
Timothy D. Heden
Affiliation:
Department of Nutrition and Exercise Physiology, University of Missouri, 217 Gwynn Hall, Columbia, MO65211, USA
Ying Liu
Affiliation:
Department of Nutrition and Exercise Physiology, University of Missouri, 217 Gwynn Hall, Columbia, MO65211, USA
Timothy J. Fairchild
Affiliation:
School of Psychology and Exercise Science, Murdoch University, Murdoch, Western Australia, Australia
*
*Corresponding author: J. A. Kanaley, fax +1 573 884 4885, email kanaleyj@missouri.edu
Rights & Permissions [Opens in a new window]

Abstract

A frequent eating pattern may alter glycaemic control and augment postprandial insulin concentrations in some individuals due to the truncation of the previous postprandial period by a subsequent meal. The present study examined glucose, insulin, C-peptide and glucose-dependent insulinotropic peptide (GIP) responses in obese individuals when meals were ingested in a high-frequency pattern (every 2 h, 6M) or in a low-frequency pattern (every 4 h, 3M) over 12 h. It also examined these postprandial responses to high-frequency, high-protein meals (6MHP). In total, thirteen obese subjects completed three 12 h study days during which they consumed 6276 kJ (1500 kcal): (1) 3M – 15 % protein and 65 % carbohydrate; (2) 6M – 15 % protein and 65 % carbohydrate; (3) 6MHP – 45 % protein and 35 % carbohydrate. Blood samples were collected every 10 min and analysed for glucose, insulin, C-peptide and GIP. Insulin total AUC (tAUC) and peak insulin concentrations (P< 0·05) were higher in the 3M condition than in the 6M condition, but there were no differences in glucose tAUC between the conditions. The 6MHP regimen (glucose: 3569 (se 83) mmol/l × min (64·3 (se 1·5) g/dl × min), insulin: 1·577 (se 0·146) pmol/l (22·7 (se 2·1) μIU/dl) for 12 h) lowered glucose and insulin excursions more so over 12 h than either the 3M regimen (glucose: 3913 (se 78) mmol/l × min (70·5 (se 1·4) g/dl × min), insulin: 2·195 (se 0·146) pmol/l × min (31·6 (se 2·1) μIU/dl × min) for 12 h) or the 6M regimen (glucose: 3902 (se 83) mmol/l × min (70·3 (se 1·5) g/dl × min), insulin: 1·861 (se 0·174) pmol/l × min (26·8 (se 2·5) μIU/dl × min) for 12 h; P< 0·01). Insulin secretion, GIP concentrations and the glucose:insulin ratio were not altered by meal frequency or composition. In obese subjects, ingestion of meals in a low-frequency pattern does not alter glucose tAUC, but increases postprandial insulin responses. The substitution of carbohydrates with protein in a frequent meal pattern results in tighter glycaemic control and reduced postprandial insulin responses.

Type
Full Papers
Copyright
Copyright © The Authors 2014 

A high fasting insulin concentration commonly exists with obesity, impaired glucose tolerance and type 2 diabetes (T2D)( Reference Pories, MacDonald and Morgan 1 Reference Schulze, Thorand and Fritsche 3 ). There is evidence in Zucker rats that the onset of hyperinsulinaemia precedes the development of obesity and muscle insulin resistance and the magnitude of hyperinsulinaemia is proportional to the duration of obesity( Reference Zarjevski, Doyle and Jeanrenaud 4 ). In addition, obese rats treated with diazoxide (inhibits insulin release) were found to exhibit reduced weight gain and improved glucose tolerance( Reference Alemzadeh, Jacobs and Pitukcheewanont 5 ). Subsequent research( Reference Alemzadeh, Langley and Upchurch 6 ) in obese human subjects with hyperinsulinaemia demonstrated that administration of diazoxide over 8 weeks led to attenuation of hyperinsulinaemia, greater weight loss, and greater decrease in body fat and reduced the acute insulin response to glucose, without inducing glucose intolerance. Based on these findings, it has been hypothesised that hyperinsulinaemia may play a more prominent role in the development of obesity, insulin resistance and T2D than previously thought and that therapies alleviating hyperinsulinaemia should be targeted for the prevention of these chronic conditions( Reference Corkey 7 Reference Rizza, Mandarino and Genest 9 ).

Although numerous conditions and factors are known to increase mean insulin concentrations, the most apparent and modifiable factor is diet – in particular, the macronutrient composition of the diet and the pattern (frequency of meals per d) of energy intake. A more frequent eating pattern was shown to result in prolonged periods of hyperglycaemia and/or hyperinsulinaemia in healthy individuals( Reference Munsters and Saris 10 ), which is suggested to be a result of truncating the postprandial period with a subsequent meal, thereby maintaining consistently high insulin concentrations throughout the day. Previously, we had also observed elevated glucose AUC throughout the day with ingestion of six meals than with that of three meals over 12 h (P< 0·05), while insulin AUC was reduced( Reference Holmstrup, Owens and Fairchild 11 ). However, Solomon et al. ( Reference Solomon, Chambers and Jeukendrup 12 ) found no difference in insulin or glucose total AUC (tAUC) over an 8 h period when comparing a low-feeding frequency pattern (two meals per d) with a high-feeding frequency pattern (twelve meals per d) in lean individuals. One limitation of these studies has been the recruitment of only non-obese, healthy individuals. Jenkins et al. ( Reference Jenkins, Ocana and Jenkins 13 ) reported that spreading the nutrient load (three meals and one snack v. thirteen snacks) resulted in reduced glucose, insulin and C-peptide concentrations in older (age range: 37–81 years), overweight (106–129 % overweight) patients with T2D. Taken together, these studies suggest a divergent response to increased meal frequency in lean individuals v. overweight individuals with T2D; thus, re-examination of this question would be prudent in a more homogeneous population to identify the influence of obesity alone.

Given the paucity of research examining the impact of meal frequency on glucose and insulin concentrations in obese individuals( Reference Solomon, Chambers and Jeukendrup 12 , Reference Jenkins, Ocana and Jenkins 13 ), the purpose of the present study was to examine postprandial glucose and insulin responses when meals are separated by 2 v. 4 h in obese individuals over a 12 h period. More specifically, we were interested in determining insulin concentrations in this population in response to altered meal frequency regimens. We speculated that shorter intervals between meals would result in prolonged hyperglycaemia with concomitant lower insulin concentrations due to altered insulin secretion in obese individuals.

The substitution of carbohydrates with protein also decreases postprandial glucose and insulin responses in both the short term( Reference Kalogeropoulou, Lafave and Schweim 14 ) and longer term( Reference Gannon and Nuttall 15 ); therefore, meal composition must also be considered. Lan-Pidhainy & Wolever( Reference Lan-Pidhainy and Wolever 16 ) reported that a high-protein meal (30 g) increased the insulin response, but had no effect on insulin secretion rate. Therefore, the second purpose of the present study was to establish the postprandial insulin response to frequent ingestion of high-protein meals over 12 h in obese individuals. We hypothesised that substituting carbohydrates with protein during a high-frequency meal pattern would reduce glucose concentrations, resulting in decreased insulin AUC and secretion rates.

Experimental methods

Subjects

A total of thirteen obese men and women (age: 29–50 years) with a fasting blood glucose concentration ( < 5·55 mmol/l; < 100 mg/dl) were recruited for the present study. The study was conducted according to the guidelines laid down in the Declaration of Helsinki, and all procedures involving human subjects were approved by the Institutional Review Board of the University of Missouri. Written informed consent was obtained from all subjects. Obese individuals with BMI 30–45 kg/m2, waist circumference >88 cm, and body fat percentage >35 %, with no smoking history, having a sedentary lifestyle ( < 60 min of physical activity per week), who were not pregnant, and having no prior history of heart, lung, kidney, endocrine, or liver disease were eligible to participate in the study( Reference Heden, Liu and Sims 17 ). No subject was taking any prescription medications known to alter glucose or lipid metabolism and was weight stable over the last 6 months. Baseline information about dietary intake, physical activity and medical history was obtained via a self-reported questionnaire.

Study design

Parts of the experimental design have been published previously( Reference Heden, Liu and Sims 17 ). All subjects completed three 12 h study days during which they consumed 6276 kJ (1500 kcal). The following regimens were used: a low-frequency meal regimen (three meals (3M): 2092 kJ/meal (500 kcal/meal: 18·8 g protein, 81·2 g carbohydrate, and 10 g fat) consumed every 4 h); a high-frequency meal regimen (six meals (6M): 1046 kJ (250 kcal/meal: 9·4 g protein, 40·6 g carbohydrate, and 5 g fat) consumed every 2 h); high-frequency, high-protein meals (6MHP): 1046 kJ/meal (250 kcal/meal: 28 g protein, 21·9 g carbohydrate, and 5 g fat) consumed every 2 h. Approximately 1 month elapsed between each study day, and the three study days were completed in a counterbalanced order. The study days were energy-matched. The meals comprised a liquid shake (Nutritional Shake, Walgreens). In the 6MHP regimen, protein was included, which consisted of Pro Complex whey protein (Pro Complex, Optimum Nutrition, Inc.)( Reference Holmstrup, Owens and Fairchild 11 ) and branched-chain amino acids and also contained a small amount of fat (approximately 2 g) sufficient to balance the fat component of the dietary conditions at 20 %. Liquid meals were used for this protocol, as previous work has shown that alterations in the macronutrient composition of liquids do not affect gastric emptying rate( Reference Goetze, Steingoetter and Menne 18 ) and so that the rate of eating could be more precisely controlled, thereby eliminating the effect of eating speed on glucose and insulin responses.

Study days

Following a 12 h overnight fast, a venous catheter was placed into the antecubital vein and kept patent with a saline drip. Blood samples were drawn from a stopcock at baseline and every 10 min for 12 h. The meals were consumed at 07.00 hours (following baseline sample collection), 11.00 and 15.00 hours on the 3M day and at 07.00, 09.00, 11.00, 13.00, 15.00 and 17.00 hours on the 6M day. The subjects were sedentary throughout the day with only minor activity. Blood samples were analysed for glucose, insulin, C-peptide and glucose-dependent insulinotropic peptide (GIP).

Anthropometric measures

As part of the screening, all subjects had their height and weight measured using a digital scale and a stadiometer. Waist and hip circumferences were measured using a measuring tape. Body fat percentage was calculated using the BOD POD® according to the manufacturer's guidelines (Cosmed Corporation). Lung volume was measured and body fat was estimated using the Siri equation.

Dietary intake assessment

As prior dietary patterns can influence postprandial responses, the subjects were required to keep a dietary record during the 3 d before each 12 h visit. The dietary record from the 1st study day was given to the subjects on their subsequent visit and they were asked to repeat the same dietary pattern before the subsequent visit( Reference Heden, Liu and Sims 17 ). Total energy content and macro/micronutrient content were determined from the records using Food Processor SQL, version 10.8 (ESHA Research).

Blood handling and analysis

Blood samples were placed in serum separator tubes, centrifuged at 3000 rpm for 15 min and stored at − 80°C until analysis. Blood glucose concentrations were determined using colorimetric assays (Fischer Scientific, Inc.) (CV − 1·8 %). Serum insulin concentrations were determined using the Immulite 1000 Immunoassay System (Siemens Healthcare Diagnostics, Inc.). C-peptide and GIP concentrations were determined with kits from Millipore using Luminex xMap Technology (Linco Research) on a Luminex 100/200 platform (Luminex Corporation). Inter-assay CV for insulin, C-peptide and GIP were 8·3, 7·9 and 9 %, and intra-assay CV for insulin, C-peptide and GIP were 6·9, 8·2 and 7·9 %, respectively. All samples for a given subject were run in the same assay.

Statistical analyses

The homeostatic model assessment of insulin resistance (HOMA-IR)( Reference Matthews, Hosker and Rudenski 19 ) and quantitative insulin sensitivity check index (QUICKI)( Reference Katz, Nambi and Mather 20 ) were used to calculate insulin resistance and sensitivity, respectively, before each condition. The tAUC for postprandial responses over 12 h was calculated using the trapezoidal method( Reference Pruessner, Kirschbaum and Meinlschmid 21 ). Postprandial glycaemic and insulin excursions were derived from the absolute difference in nadir (baseline insulin concentrations before each meal) and peak concentrations.

Insulin secretion was determined using the C-peptide data. A pulse profile was analysed using a multi-parameter deconvolution technique (AutoDecon, Pulse_XP software; University of Virginia) that derives quantitative estimates of attributes of C-peptide secretory pulses and half-life from measured C-peptide concentrations( Reference Engdahl, Veldhuis and Farrell 22 , Reference Johnson, Veldhuis and Grimmichova 23 ). A Gaussian distribution of secretory rate was assumed using the serum C-peptide concentration value and it was assumed to match insulin concentration at a 1:1 ratio. Basal secretion was estimated for each condition. C-peptide pulses were considered significant if they were able to be distinguished from zero with a 95 % statistical significance as reported previously( Reference Engdahl, Veldhuis and Farrell 22 , Reference Pritzlaff, Wideman and Weltman 24 ).

Statistical analyses were carried out using Statistical Package for the Social Sciences statistical software, version 19.0 (IBM, Inc.). For the primary analysis, a mixed-model ANOVA with repeated measures was used to compare the tAUC values between the conditions for all variables, and the baseline value on each study day for each respective hormone was used as a covariate. As baseline values can influence the hormonal response, correction for the baseline value of each subject was performed to control for day-to-day variation. Variables for the deconvolution analysis were also analysed with an AVOVA with repeated measures. A Pearson product correlation was run on the hormone variables. Statistical significance was set at P≤ 0·05, and values are reported as means with their standard errors.

For the bootstrapping analysis, each subject's hormone concentration at each time point from one study day was subtracted from that on the comparison study day at the same time point (e.g. 3M − 6M)( Reference Kanaley, Weltman and Pieper 25 ). The change in hormone concentrations was plotted over time with simultaneous 95 % confidence bands. The 95 % confidence regions were derived using the bootstrapping technique. This 95 % confidence region avoids the problem of multiple point-wise comparisons. A significant response was defined as occurring when the lower 95 % confidence limit for the curve was greater than zero, and a significant suppression of hormone release was defined as occurring when the upper 95 % confidence limit for the regression curve was less than zero( Reference Kanaley, Weltman and Pieper 25 ). This analysis was carried out for each study day for glucose and insulin concentrations.

Results

In total, eleven women and three men completed the study. No significant differences were found in fasting glucose, insulin, C-peptide or GIP concentrations between the study days. The mean fasting insulin concentration across the three study days was 68·8 (se 6·9) pmol/l (9·9 (se 1·0) μIU/ml), while the mean fasting glucose concentration was 4·48 (se 0·122) mmol/l (80·8 (se 2·2) mg/dl). The subjects remained weight stable during the study and weighed 100·0 (se 3·7) kg (weight gain/loss < 2 kg) and had a BMI of 35·5 (se 1·0) kg/m2. They had a mean body fat percentage of 45·9 (se 1·8) %. Their HOMA-IR was 2·1 (se 0·2) and insulin sensitivity (QUICKI) was 0·32 (se 0·05). There were no dietary differences (energy consumed or composition) during the 3 d before each condition. The subjects consumed approximately 10 460 kJ (2500 kcal) during each of the 3 d before the study day (48 % carbohydrate, 15 % protein and 37 % fat)( Reference Heden, Liu and Sims 17 ).

The patterns of postprandial glucose and insulin responses over the 12 h period are shown in Fig. 1(a) and (b), respectively. There were no differences in glucose tAUC adjusted for fasting glucose concentrations between the 3M and 6M regimens (P= 0·98; Fig. 2(a)), but postprandial changes in peak glucose concentrations were greater in the 3M condition at the first meal (2·18 (se 0·27) mmol/l; 39·2 (se 4·8) mg/dl) than in both the 6M and 6MHP conditions (1·53 (se 0·21) and 0·87 (se 0·16) mmol/l (27·5 (se 3·7) and 15·6 (se 2·9) mg/dl), respectively, P< 0·0001) (Fig. 1(a)). Postprandial changes in peak glucose concentrations were also significantly greater in the 6M condition than in 6MHP condition (P< 0·001; Fig. 1(a)). Within each study day, there was no significant difference in the change in peak concentrations with each meal, and thus the glucose response at subsequent meals did not differ from that at the first meal after 12 h of fasting. Comparison of the postprandial glucose response on the 3M day with that on the 6M day revealed periods of higher glucose concentrations on the 3M day (07.30–07.40, 07.50–08.00, 12.20–12.40, 13.00–13.20, 15.50–16.00, and 16.20–17.20 hours; total 130 min/d) (Fig. 3(a)) and lower glucose concentrations (the lines passing below the x-axis) at the second, fourth and fifth meals (09.20–09.40, 13.30–15.10, and 17.30–19.00 hours; total 210 min/d), indicating that overall glucose concentrations were lower for longer periods of time during the day while on the 3M regimen.

Fig. 1 Patterns of (a) glucose, (b) insulin and (c) glucose-dependent insulinotropic peptide (GIP) responses over 12 h for each study day. Values are means (n 13, two men/eleven women), with their standard errors. , low-frequency meals; , high-frequency meals; , high-frequency, high-protein meals; , meal. To convert glucose in mg/dl to mmol/l, multiply by 0·0555. To convert insulin in μIU/ml to pmol/l, multiply by 6·945.

Fig. 2 Total AUC adjusted for fasting (a) glucose, (b) insulin and (c) glucose-dependent insulinotropic peptide (GIP) concentrations. 3M, low-frequency meals; 6M, high-frequency meals; 6MHP, high-frequency, high-protein meals. Values are means (n 13, two men/eleven women), with their standard errors represented by vertical bars. *** Mean value was significantly different from those during the 3M and 6M regimens (P< 0·001). †† Mean value was significantly different from those during the 3M and 6M regimens (P< 0·01). ‡ Mean value was significantly different from that during the 6M regimen (P< 0·05). To convert glucose in g/dl to mmol/l, multiply by 55·5. To convert insulin in μIU/dl to pmol/l, multiply by 0·06 945.

Fig. 3 Comparison of the low-frequency meal and the high-frequency meal days for (a) glucose and (b) insulin concentrations over 12 h. The difference between the study days () and simultaneous 95 % confidence limits () are shown. Significant stimulation of glucose or insulin release by the meal occurred when the lower 95 % confidence limit was greater than zero. Significant suppression of glucose or insulin release occurred when the upper 95 % confidence limit was less than zero. , Meal. To convert glucose in mg/dl to mmol/l, multiply by 0·0555. To convert insulin in μIU/ml to pmol/l, multiply by 6·945.

Insulin tAUC adjusted for fasting insulin concentrations was higher during the 3M regimen than during the 6M regimen (P< 0·05; Fig. 2(b)). Postprandial insulin excursions on the 3M day (mean: 637 (se 93·7) pmol/l; 91·8 (se 13·5) μIU/ml) were significantly greater (P< 0·001) at all meals than those on the 6M day (mean: 384 (se 75) pmol/l; 55·3 (se 10·8) μIU/ml). Insulin concentrations closely followed meal ingestion: insulin concentrations on the 3M day were higher than those on the 6M day at time points that corresponded with meal ingestion (07.20–09.10, 11.30–13.20, and 15.40–17.20 hours; total 320 min/d) (Fig. 3(b)), while higher insulin concentrations were observed on the 6M day only at those intervals when additional meals were consumed (09.20–11.10, 13.30–15.10, and 17.30–18.50 hours; total 290 min/d), indicating that insulin concentrations were higher for slightly longer periods of time while on the 3M regimen.

Examination of the tAUC for each meal revealed that on the 3M and 6M days there was no significant difference across the meals in glucose or insulin tAUC at each respective meal, although there was a trend for slightly lower glucose tAUC for the meals ingested earlier in the day than for those ingested later in the day. Insulin tAUC exhibited a similar trend in the 3M condition, but not in the 6M condition.

The 6MHP condition resulted in a significantly lower glucose tAUC compared with both the 3M and 6M conditions (P< 0·01 and P< 0·01, respectively) (Fig. 2(a)). Peak glucose concentrations on the 6MHP day were significantly lower (P< 0·01) than those on the 3M day and approached significance on the 6M day (P< 0·06). Insulin tAUC was greater on both the 6M and 3M days than on the 6MHP day (P< 0·0001; Fig. 2(b)). Peak insulin responses were greater on the 3M day than on the 6MHP day at each corresponding meal of the 3M day (P< 0·01), but peak insulin responses on the 6M day were significantly greater only at the third and fifth meals than those on the 6MHP day (P< 0·01; Fig. 1(b)). The contrast in glycaemic and insulin excursions during the 6MHP regimen compared with those during the 6M and 3M regimens is shown in Fig. 4. Compared with those in the 6M condition, glucose concentrations in the 6MHP condition were usually lower for about 50 min after meal ingestion (Fig. 4(a)), while insulin concentrations were lower at the second, third and fourth meals and for very short periods of time at the fifth and sixth meals (Fig. 4(b)). In comparison with those in the 3M condition, glucose concentrations in the 6MHP condition were lower for approximately 80 min after meal ingestion at the first, third and fifth meals (Fig. 4(c)). Insulin concentrations followed a very similar trend of being much higher in the 3M condition for approximately 2 h after meal ingestion (Fig. 4(d)). In the 6MHP condition, there were no differences in glucose and insulin tAUC across the meals on the study day.

Fig. 4 Comparison of the high-frequency meal minus high-frequency, high-protein meal (6MHP) and low-frequency meal minus 6MHP days for (a, c) glucose and (b, d) insulin concentrations, respectively, over 12 h. More details are given in Fig. 3. , Meal. To convert glucose in mg/dl to mmol/l, multiply by 0·0555. To convert insulin in μIU/ml to pmol/l, multiply by 6·945.

The highest glucose:insulin ratio occurred at fasting and immediately before ingestion of each meal (Fig. 5(a)). After meal ingestion, this ratio dropped rapidly as the magnitude of increase in insulin concentrations was greater than that of increase in glucose concentrations. Approximately 40 min after meal ingestion, the ratio began to rise under all conditions. The slope of this rise between 40 and 120 min after meal ingestion demonstrated a condition effect, such that a significantly lower slope was observed in the 3M condition than in the 6MHP (P< 0·01) and 6M (P< 0·05) conditions. There was no difference in the slope between the 6M and 6MHP conditions. Furthermore, there was no difference in this effect between the meals across the day.

Fig. 5 (a) Patterns of the ratio of glucose concentration:insulin concentration over 12 h for each study day, (b) comparison of the low-frequency meal minus high-frequency meal (6M) ratio of glucose concentration:insulin concentration and (c) comparison of the 6M minus high-frequency, high-protein meal ratio of glucose concentration:insulin concentration. More details are given in Fig. 3. , Meal. To convert glucose/insulin in mg per dl/μIU per ml to mmol per l/pmol per l, multiply by 0·00801.

There were no differences in C-peptide and GIP tAUC between the study days for meal frequency or composition. The pattern of GIP response is shown in Fig. 1(c), and as can be seen from the tAUC, the response was very similar across all the study days (Fig. 2(c)). Deconvolution of the C-peptide data provided insights into insulin secretion characteristics for the 12 h period. There were no differences in insulin secretion characteristics between the study days (Table 1). Fasting GIP and C-peptide concentrations were significantly correlated with insulin tAUC (r 0·449, P< 0·01 and r 0·751, P< 0·000, respectively).

Table 1 Deconvolution parameters for C-peptide (Mean values with their standard errors, n 13)

LFM, low-frequency meals; HFM, high-frequency meals, HP, high protein.

Discussion

The eating regimen of frequent meals has become common practice, but the impact of such an eating pattern on glycaemic and insulinaemic excursions over the course of a 12 h period has not been well studied, particularly in obese individuals who often demonstrate hyperinsulinaemia while being normoglycaemic. The findings from the present study show, for the first time, that in obese individuals: (1) larger less frequent meals (3M) result in greater insulin responses (peak insulin concentrations and 12 h AUC) than what is observed with a 6M pattern; (2) while peak glucose concentrations were higher during the 3M regimen, glucose concentrations remained largely unaffected by the pattern (3M v. 6M) of energy intake during the study day; (3) substituting carbohydrates with protein reduced glucose and insulin concentrations substantially throughout the day; (4) insulin secretion and insulin clearance were not altered by acute changes in meal frequency or composition.

While glucose tAUC was not different between the 3M and 6M regimens, the postprandial responses to meals were very different between the conditions. The 3M pattern had a larger energy and carbohydrate load/meal, thus resulting in higher peak glucose concentrations after meal ingestion and for a number of short intervals throughout the day. Peak glucose values were 30 % higher following the ingestion of the initial meal on the 3M day than on the 6M day, but no differences were observed after the ingestion of subsequent meals. This observation contrasts our early finding in healthy young individuals that a 6M pattern resulted in higher glucose concentrations across the day( Reference Holmstrup, Owens and Fairchild 11 ). However, the findings parallel with those of Solomon et al. ( Reference Solomon, Chambers and Jeukendrup 12 ), who compared glucose/insulin responses between meals consumed at a low frequency (every 4 h) or a high frequency (every 40 min) for 8 h. Similarly, Munsters & Saris( Reference Munsters and Saris 10 ) demonstrated greater insulin and glucose fluctuations but lower glucose AUC in healthy young men, following the ingestion of a low-frequency diet (three meals per d) or a high-frequency diet (fourteen meals per d).

Despite equivalent glucose concentrations, overall insulin concentrations tended to be approximately 10 % higher on the 3M day, and this finding is in line with previous data from our laboratory( Reference Heden, Liu and Sims 17 ). The large insulin excursions closely tracked when the meals were ingested (Fig. 3) on each of the respective days, but insulin responses were greater on the 3M day for about 390 min across the day while being greater on the 6M day for 290 min. Thus, if the hypothesis regarding chronically elevated insulin concentrations as being deleterious( Reference Pories and Dohm 8 , Reference Corkey 26 ) holds true, then meals that are high in carbohydrates consumed in a 6M pattern may be beneficial for obese individuals, particularly if they have elevated insulin responses to meals. Future long-term studies manipulating meal frequency need to be conducted to establish the long-term effects that this may have on insulin secretion and/or insulin resistance in a variety of populations.

A number of studies have reported diurnal variations in glucose tolerance in lean individuals( Reference Saad, Dalla Man and Nandy 27 , Reference Van Cauter, Shapiro and Tillil 28 ), which may be a circadian variation in the responsiveness of α-cells to glucose, resulting in an attenuation in insulin sensitivity later in the day( Reference Van Cauter, Shapiro and Tillil 28 ). However, in obese subjects, this circadian variation is believed to be absent( Reference Lee, Ader and Bray 29 ), which is supported by our data. Although we did not include direct measures of insulin sensitivity, there were only slight differences in postprandial insulin or glucose concentrations or the glucose:insulin ratio in response to subsequent meals throughout the day in each of the dietary conditions studied. Slight divergences between glucose and insulin responses throughout the day are expected, and these divergences may be more apparent in obese individuals, as it is often not uncommon to find normal glucose responses in this population but higher insulin concentrations to achieve these levels.

We also tested the hypothesis that substituting carbohydrates with protein would lower postprandial blood glucose and insulin responses. As expected, there was a significant decrease in the absolute concentrations of blood glucose and insulin in response to the 6MHP condition in the present study, which is most probably due to the reduced total carbohydrate load. When compared with the 6M condition, the 6MHP condition resulted in lower glucose concentrations for approximately 310 min (approximately 43 % of the day) over the 12 h period, while insulin concentrations were lower about 260 min (approximately 36 %) throughout the day. The insulinotropic effects of protein are well characterised in the literature. Frid et al. ( Reference Frid, Nilsson and Holst 30 ) demonstrated that addition of whey protein to meals containing rapidly digested and absorbed carbohydrates resulted in an insulinotropic effect, thereby reducing glucose concentrations. Notably, however, Lan-Pidhainy & Wolever( Reference Lan-Pidhainy and Wolever 16 ) demonstrated postprandial hyperinsulinaemia only when 30 g of protein are consumed. In the present study, the subjects ingested approximately 28 g of whey protein in the 6MHP condition. When assessing the deconvolution parameters for C-peptide, there appeared to be no change in any of the secretory or half-life parameters assessed in the present study. Similarly, neither the insulinogenic ratio (tAUC insulin:tAUC glucose) nor the glucose:insulin ratio provides support for an insulinotropic effect in the 6MHP condition in the present study. Indeed, there was a trend for the glucose:insulin ratio to be higher in the 6MHP condition (Fig. 5(a)), translating into extended periods throughout the day (approximately 120 min in the morning and approximately 80 min in the afternoon; Fig. 5(c)), while the glucose:insulin ratio was elevated (insulinotropic effect would result in a reduction of this ratio).

Other mechanisms associated with the hypoglycaemic effect of protein are suggested to be due to differences in gastric emptying( Reference Pories and Dohm 8 ) or enhanced insulin secretion through augmented GIP and glucagon-like peptide 2 secretion( Reference Rizza, Mandarino and Genest 9 ). Frid et al. ( Reference Frid, Nilsson and Holst 30 ) observed that postprandial GIP responses were higher after ingestion of whey than after that of a reference meal containing no whey (alternate source of protein). While we observed no differences in GIP levels between study days (6M v. 6MHP), it is important to note that the present study substituted protein for carbohydrate as opposed to adding it to the meal. Thus, the lack of a significant difference between the 6MHP and 6M regimens is surprising. Finally, it is of interest to note the appearance of a possible diurnal trend in the GIP responses to meals in the present study, with a trend for an increasing peak GIP response at subsequent meals (Fig. 1(c)). While a more rapid early GIP response following ingestion of a standardised meal in the morning compared with the afternoon (AUC in the first 30 min after meal ingestion) was observed in healthy subjects in previous research, there were no differences in GIP concentrations in the remaining 270 min( Reference Lindgren, Mari and Deacon 31 ) or peak GIP concentrations. Further investigation into GIP responses over the course of the day in both healthy and clinical populations would be of interest.

Surprisingly, there are a limited number of studies that have examined postprandial glycaemic control in response to different meal frequency patterns, and these have utilised discernible study protocols. The strength of the present study is that we assessed this response over a 12 h period and captured possible diurnal variations in glucose tolerance( Reference Van Cauter, Shapiro and Tillil 28 ). Furthermore, the frequent sampling techniques allowed us to more carefully analyse the pattern of responses compared with some of the previous studies that have sampled hourly( Reference Munsters and Saris 10 , Reference Jenkins, Ocana and Jenkins 13 ). In addition, many of the previous studies have recruited only lean healthy individuals( Reference Munsters and Saris 10 , Reference Solomon, Chambers and Jeukendrup 12 ), and the study that did recruit individuals with T2D recruited a heterogeneous group based on age, sex and body weight status( Reference Jenkins, Ocana and Jenkins 13 ). One limitation of the present study is that we did not include a 3MHP trial. We did not include this group as the present study was modelled after our previous study in lean subjects( Reference Holmstrup, Owens and Fairchild 11 ). In hindsight, this arm would have allowed us to establish the effect of meal frequency on the HP condition. In addition, it could be argued that we should have included more energy in the meals, as larger meals may more closely reflect what these subjects habitually consume; however, we selected an energy intake that would keep these subjects in energy balance during the study day in light of the fact that they were physically inactive all day. In addition, the results represent the short-term response to meal frequency and composition and provide insights into the glycaemic responses. However, the present study does not identify whether the beneficial responses observed with a 6M pattern would still be manifested in a long-term study. Future research needs to address whether long-term changes in meal frequency alter insulin sensitivity.

The present study demonstrated that in an obese population ingestion of more frequent meals (six-meal eating pattern v. three-meal eating pattern) (1) results in no change in glucose tAUC despite significantly lower insulin tAUC and (2) reduces postprandial insulin excursions without altering C-peptide secretory parameters or GIP tAUC. Further research is needed in individuals with T2D to establish the effects of long-term ramifications of adopting frequent meal patterns on insulin sensitivity, clearance and secretion. Furthermore, the substitution of carbohydrates with protein reduces insulin and glucose tAUC and does not alter the glucose:insulin ratio, secretory parameters for C-peptide or GIP responses. Finally, no significant diurnal patterns emerged across any of the parameters investigated in the present study.

Acknowledgements

The authors cordially thank the subjects for contributing a tremendous amount of their time to the present study and the nurses on the Clinical Research Unit at the University of Missouri.

The present study was partially supported by NIH R21DK084467. The NIH had no role in the design and analysis of the study or in the writing of this article.

The authors’ contributions are as follows: J. A. K. conceived the study, designed the research, conducted the research, analysed the data, edited the final version of the article, and had primary responsibility for the final content of article; T. D. H. conducted the research, analysed the data, and edited the final version of the article; Y. L. conducted the research and analysed the data; T. J. F. conceived the study, designed the research, analysed the data, and edited the final version of article.

None of the authors has any conflicts of interest to declare.

References

1 Pories, WJ, MacDonald, KG Jr, Morgan, EJ, et al. (1992) Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. Am J Clin Nutr 55, Suppl. 2, 582S585S.CrossRefGoogle ScholarPubMed
2 Reed, MA, Pories, WJ, Chapman, W, et al. (2011) Roux-en-Y gastric bypass corrects hyperinsulinemia implications for the remission of type 2 diabetes. J Clin Endocrinol Metab 96, 25252531.CrossRefGoogle ScholarPubMed
3 Schulze, MB, Thorand, B, Fritsche, A, et al. (2012) Body adiposity index, body fat content and incidence of type 2 diabetes. Diabetologia 55, 16601667.CrossRefGoogle ScholarPubMed
4 Zarjevski, N, Doyle, P & Jeanrenaud, B (1992) Muscle insulin resistance may not be a primary etiological factor in the genetically obese fa/fa rat. Endocrinology 130, 15641570.Google Scholar
5 Alemzadeh, R, Jacobs, W & Pitukcheewanont, P (1996) Antiobesity effect of diazoxide in obese Zucker rats. Metabolism 45, 334341.Google Scholar
6 Alemzadeh, R, Langley, G, Upchurch, L, et al. (1998) Beneficial effect of diazoxide in obese hyperinsulinemic adults. J Clin Endocrinol Metab 83, 19111915.Google ScholarPubMed
7 Corkey, BE (2012) Banting lecture 2011: hyperinsulinemia: cause or consequence? Diabetes 61, 413.CrossRefGoogle ScholarPubMed
8 Pories, WJ & Dohm, GL (2012) Diabetes: have we got it all wrong? Hyperinsulinism as the culprit: surgery provides the evidence. Diabetes Care 35, 24382442.Google Scholar
9 Rizza, RA, Mandarino, LJ, Genest, J, et al. (1985) Production of insulin resistance by hyperinsulinaemia in man. Diabetologia 28, 7075.Google Scholar
10 Munsters, MJ & Saris, WH (2012) Effects of meal frequency on metabolic profiles and substrate partitioning in lean healthy males. PLOS ONE 7, e38632.Google Scholar
11 Holmstrup, M, Owens, C, Fairchild, T, et al. (2010) Effect of meal frequency on glucose and insulin excursions over the course of a day. e-SPEN 5, e277e280.CrossRefGoogle Scholar
12 Solomon, TP, Chambers, ES, Jeukendrup, AE, et al. (2008) The effect of feeding frequency on insulin and ghrelin responses in human subjects. Br J Nutr 100, 810819.Google Scholar
13 Jenkins, DJ, Ocana, A, Jenkins, AL, et al. (1992) Metabolic advantages of spreading the nutrient load: effects of increased meal frequency in non-insulin-dependent diabetes. Am J Clin Nutr 55, 461467.Google Scholar
14 Kalogeropoulou, D, Lafave, L, Schweim, K, et al. (2008) Leucine, when ingested with glucose, synergistically stimulates insulin secretion and lowers blood glucose. Metabolism 57, 17471752.CrossRefGoogle ScholarPubMed
15 Gannon, MC & Nuttall, FQ (2004) Effect of a high-protein, low-carbohydrate diet on blood glucose control in people with type 2 diabetes. Diabetes 53, 23752382.Google Scholar
16 Lan-Pidhainy, X & Wolever, TM (2010) The hypoglycemic effect of fat and protein is not attenuated by insulin resistance. Am J Clin Nutr 91, 98105.CrossRefGoogle Scholar
17 Heden, TD, Liu, Y, Sims, LJ, et al. (2013) Meal frequency differentially alters postprandial triacylglycerol and insulin concentrations in obese women. Obesity (Silver Spring) 21, 123129.CrossRefGoogle ScholarPubMed
18 Goetze, O, Steingoetter, A, Menne, D, et al. (2007) The effect of macronutrients on gastric volume responses and gastric emptying in humans: a magnetic resonance imaging study. Am J Physiol Gastrointest Liver Physiol 292, G11G17.CrossRefGoogle ScholarPubMed
19 Matthews, DR, Hosker, JP, Rudenski, AS, et al. (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412419.CrossRefGoogle ScholarPubMed
20 Katz, A, Nambi, SS, Mather, K, et al. (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85, 24022410.CrossRefGoogle ScholarPubMed
21 Pruessner, JC, Kirschbaum, C, Meinlschmid, G, et al. (2003) Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 28, 916931.CrossRefGoogle ScholarPubMed
22 Engdahl, JH, Veldhuis, JD & Farrell, PA (1995) Altered pulsatile insulin secretion associated with endurance training. J Appl Physiol 79, 19771985.Google Scholar
23 Johnson, ML, Veldhuis, PP, Grimmichova, T, et al. (2010) Validation of a deconvolution procedure (AutoDecon) for identification and characterization of fasting insulin secretory bursts. J Diabetes Sci Technol 4, 12051213.Google Scholar
24 Pritzlaff, CJ, Wideman, L, Weltman, JY, et al. (1999) Impact of acute exercise intensity on pulsatile growth hormone release in men. J Appl Physiol 87, 498504.CrossRefGoogle ScholarPubMed
25 Kanaley, JA, Weltman, JY, Pieper, KS, et al. (2001) Cortisol and growth hormone responses to exercise at different times of day. J Clin Endocrinol Metab 86, 28812889.Google ScholarPubMed
26 Corkey, BE (2012) Diabetes: have we got it all wrong? Insulin hypersecretion and food additives: cause of obesity and diabetes? Diabetes Care 35, 24322437.Google Scholar
27 Saad, A, Dalla Man, C, Nandy, DK, et al. (2012) Diurnal pattern to insulin secretion and insulin action in healthy individuals. Diabetes 61, 26912700.Google Scholar
28 Van Cauter, E, Shapiro, ET, Tillil, H, et al. (1992) Circadian modulation of glucose and insulin responses to meals: relationship to cortisol rhythm. Am J Physiol 262, E467E475.Google Scholar
29 Lee, A, Ader, M, Bray, GA, et al. (1992) Diurnal variation in glucose tolerance. Cyclic suppression of insulin action and insulin secretion in normal-weight, but not obese, subjects. Diabetes 41, 750759.CrossRefGoogle Scholar
30 Frid, AH, Nilsson, M, Holst, JJ, et al. (2005) Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects. Am J Clin Nutr 82, 6975.Google Scholar
31 Lindgren, O, Mari, A, Deacon, CF, et al. (2009) Differential islet and incretin hormone responses in morning versus afternoon after standardized meal in healthy men. J Clin Endocrinol Metab 94, 28872892.CrossRefGoogle ScholarPubMed
Figure 0

Fig. 1 Patterns of (a) glucose, (b) insulin and (c) glucose-dependent insulinotropic peptide (GIP) responses over 12 h for each study day. Values are means (n 13, two men/eleven women), with their standard errors. , low-frequency meals; , high-frequency meals; , high-frequency, high-protein meals; , meal. To convert glucose in mg/dl to mmol/l, multiply by 0·0555. To convert insulin in μIU/ml to pmol/l, multiply by 6·945.

Figure 1

Fig. 2 Total AUC adjusted for fasting (a) glucose, (b) insulin and (c) glucose-dependent insulinotropic peptide (GIP) concentrations. 3M, low-frequency meals; 6M, high-frequency meals; 6MHP, high-frequency, high-protein meals. Values are means (n 13, two men/eleven women), with their standard errors represented by vertical bars. *** Mean value was significantly different from those during the 3M and 6M regimens (P< 0·001). †† Mean value was significantly different from those during the 3M and 6M regimens (P< 0·01). ‡ Mean value was significantly different from that during the 6M regimen (P< 0·05). To convert glucose in g/dl to mmol/l, multiply by 55·5. To convert insulin in μIU/dl to pmol/l, multiply by 0·06 945.

Figure 2

Fig. 3 Comparison of the low-frequency meal and the high-frequency meal days for (a) glucose and (b) insulin concentrations over 12 h. The difference between the study days () and simultaneous 95 % confidence limits () are shown. Significant stimulation of glucose or insulin release by the meal occurred when the lower 95 % confidence limit was greater than zero. Significant suppression of glucose or insulin release occurred when the upper 95 % confidence limit was less than zero. , Meal. To convert glucose in mg/dl to mmol/l, multiply by 0·0555. To convert insulin in μIU/ml to pmol/l, multiply by 6·945.

Figure 3

Fig. 4 Comparison of the high-frequency meal minus high-frequency, high-protein meal (6MHP) and low-frequency meal minus 6MHP days for (a, c) glucose and (b, d) insulin concentrations, respectively, over 12 h. More details are given in Fig. 3. , Meal. To convert glucose in mg/dl to mmol/l, multiply by 0·0555. To convert insulin in μIU/ml to pmol/l, multiply by 6·945.

Figure 4

Fig. 5 (a) Patterns of the ratio of glucose concentration:insulin concentration over 12 h for each study day, (b) comparison of the low-frequency meal minus high-frequency meal (6M) ratio of glucose concentration:insulin concentration and (c) comparison of the 6M minus high-frequency, high-protein meal ratio of glucose concentration:insulin concentration. More details are given in Fig. 3. , Meal. To convert glucose/insulin in mg per dl/μIU per ml to mmol per l/pmol per l, multiply by 0·00801.

Figure 5

Table 1 Deconvolution parameters for C-peptide (Mean values with their standard errors, n 13)